ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,375Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 617

$527K Total Retail Price of All Prescriptions

Rank: 86 out of 617

501 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

4% of this provider’s 8,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 567 442 1 1
HYDROCODONE-ACETAMINOPHEN 401 218 S3 2 8
SIMVASTATIN 384 349 3 2
METOPROLOL TARTRATE 378 309 4 11
LISINOPRIL 373 339 5 5
OMEPRAZOLE 299 253 6 3
FUROSEMIDE 249 221 7 4
METFORMIN HCL 243 200 8 9
CITALOPRAM HBR 242 165 9 18
TAMSULOSIN HCL 218 184 10 26
TRIAMTERENE-HYDROCHLOROTHIAZID 195 171 11 122
GLYBURIDE 184 165 R 12 84
ATORVASTATIN CALCIUM 178 141 13 14
AMLODIPINE BESYLATE 177 163 14 6
ZOLPIDEM TARTRATE 153 111 15 23
POTASSIUM CHLORIDE 150 141 16 10
TRAMADOL HCL 148 127 17 15
NAPROXEN 141 96 18 101
METOPROLOL SUCCINATE 134 129 19 12
TRIAMTERENE-HCTZ 124 113 20 47
GABAPENTIN 112 72 21 16
CYCLOBENZAPRINE HCL 109 46 R 22 74
ROPINIROLE HCL 101 83 23 66
LOSARTAN-HYDROCHLOROTHIAZIDE 97 94 24 46
ISOSORBIDE MONONITRATE ER 95 83 25 52
PRAVASTATIN SODIUM 95 80 25 21
DIGOXIN 95 95 25 48
CARVEDILOL 86 71 28 19
NEXIUM 83 48 29 43
CARBIDOPA-LEVODOPA 75 75 30 69
ATENOLOL 73 59 31 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 72 32 29
SPIRONOLACTONE 72 60 32 42
FLUOXETINE HCL 70 0 34 73
TRIAMCINOLONE ACETONIDE 70 54 34 102
GLYBURIDE-METFORMIN HCL 70 57 R 34 157
DIOVAN 70 58 34 41
WARFARIN SODIUM 69 68 38 7
MECLIZINE HCL 69 59 38 150
COMBIVENT 69 68 38 187
SERTRALINE HCL 67 59 41 20
RANITIDINE HCL 67 39 41 40
AMOX TR-POTASSIUM CLAVULANATE 67 58 41 184
PANTOPRAZOLE SODIUM 66 52 44 37
LANTUS 66 28 44 39
PREDNISONE 65 54 46 31
CLONIDINE HCL 64 62 47 55
METHYLPHENIDATE HCL 59 25 48 215
AMITRIPTYLINE HCL 58 18 R 49 56
JANTOVEN 58 32 49 244
CIPROFLOXACIN HCL 58 45 49 60
CLOPIDOGREL 57 47 52 53
SYMBICORT 57 56 52 141
TRAZODONE HCL 56 40 54 51
PROAIR HFA 55 40 55 75
TRICOR 55 42 55 83
DONEPEZIL HCL 55 54 55 30
LOSARTAN POTASSIUM 52 39 58 22
BENAZEPRIL HCL 52 41 58 44
ALLOPURINOL 51 46 60 27
FENOFIBRATE 51 51 60 58
NAMENDA 51 42 60 35
TERAZOSIN HCL 50 50 63 96
CEPHALEXIN 50 35 63 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.